(3R)-3-(Pyrrolidin-1-YL)pyrrolidine → N-{(1S,2R,3S,4R)-4-[(R)-2-[1,3']Bipyrrolidinyl-1'-yl-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl}-propionamide hydrochloride

Participants

Role	Name	HCID	Charge
Reactant	(3R)-3-(Pyrrolidin-1-YL)pyrrolidine	HCID 7176272	—
Reactant	N-{(1S,2R,3S,4R)-4-[2-((R)-3-amino-pyrrolidin-1-yl)-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl}-2-benzyloxy-acetamide trifluoroacetate	HCID 66630722	—
Reactant	N-[(1S,2R,3S,4R)-4-[2-Chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl]-propionamide	HCID 86622630	—
Product	N-{(1S,2R,3S,4R)-4-[(R)-2-[1,3']Bipyrrolidinyl-1'-yl-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl}-propionamide hydrochloride	HCID 66630578	—

Reaction Steps

The title compound is prepared analogously to N-{(1S,2R,3S,4R)-4-[2-((R)-3-amino-pyrrolidin-1-yl)-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl}-2-benzyloxy-acetamide trifluoroacetate (Example 1 step 2) by replacing 2-benzyloxy-N-{(1S,2R,3S,4R)-4-[2-chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl}-acetamide with N-{(1S,2R,3S,4R)-4-[2-chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,3-dihydroxy-cyclopentyl}-propionamide (Intermediate J) and by replacing (3R)-3-aminopyrrolidine with (R)-[1,3′]bipyrrolidinyl (Intermediate N). (MH+ 625.4)

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US08318750B2
Source dataset	uspto-grants-2012_11
ORD ID	ord-2443b588cc074f74be17fb14547db749
Source note	uspto-grants-2012_11